e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Asthma and COPD: diseases with different phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Physiological and inflammatory phenotypic comparisons between non-smoking and smoking COPD
N. Iyer, B. Brashier, S. Madas, J. Londhe, S. Salvi, P. Barnes (Pune, India; London, United Kingdom)
Source:
Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Session:
Asthma and COPD: diseases with different phenotypes
Session type:
Oral Presentation
Number:
3042
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Iyer, B. Brashier, S. Madas, J. Londhe, S. Salvi, P. Barnes (Pune, India; London, United Kingdom). Physiological and inflammatory phenotypic comparisons between non-smoking and smoking COPD. Eur Respir J 2013; 42: Suppl. 57, 3042
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Change in lung functions in patients with COPD during 6MWT
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Airway wall thinness and COPD: Analysis of spatially comparable airways. The MESA COPD study
Source: Annual Congress 2013 –Functional imaging of the lung, airways and diaphragm
Year: 2013
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
Sympathetic activation is related to exercise limitation in COPD
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Plasma cytokine levels in non-smoking and smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept